Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,839.40
-8.3188-0.45%
Number of Gainers:5
Number of Losers:13
Number of Flat:1
PE:- -
High:1,843.55
Open:1,843.55
Low:1,812.56
Close:1,847.72
Volume:93.66M
Turnover:5.78B
Market Cap:1.50T
Float Cap:1.46T

Loading ...

AstraZeneca Can Overcome Recent Trial Setbacks

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

AstraZeneca, Daiichi Drug Has Good Lung-Cancer Data, but Competition Awaits

Dow Jones
·
Sep 14

BioNTech and OncoC4 Report Survival Gains for Gotistobart in Phase 3 Squamous NSCLC Trial

TIPRANKS
·
Sep 14

U.S. Stocks on the MOVE-US Energy Stocks, Baldwin, Johnson & Johnson

Reuters
·
Sep 14

Analysts Offer Insights on Consumer Cyclical Companies: FIGS (FIGS), Macy’s (M) and Lakeland Industries (LAKE)

TIPRANKS
·
Sep 14

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

TIPRANKS
·
Sep 14

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Deep News
·
Sep 14

BioNTech's Lung Cancer Drug Nearly Doubles Survival in Late-Stage Trial, Boosting Oncology Pivot

Stock News
·
Sep 14

AstraZeneca reports results from DESTINY-Lung04 trial

TIPRANKS
·
Sep 14

AstraZeneca reports updated exploratory results from ADAURA trial

TIPRANKS
·
Sep 14

BioNTech, OncoC4 announce first median overall survival data from PRESERVE-003

TIPRANKS
·
Sep 14

BioNTech, OncoC4 Report Positive Overall Survival Data From Phase 3 Trial of Gotistobart in Lung Cancer

MT Newswires Live
·
Sep 14

Mabion Signs Deal with Novavax Expanding Cooperation to Analytical Services for Early-Stage Pipeline Projects

Reuters
·
Sep 14

Mabion Sa - Deal Covers Implementation and Provision of Analytical Services for Novavax's Early-Stage Pipeline Projects

THOMSON REUTERS
·
Sep 14

Mabion Sa - Signs Statement of Work #12 with Novavax to Expand Cooperation Under Existing Manufacturing Agreement

THOMSON REUTERS
·
Sep 14

Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months

MT Newswires Live
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Astrazeneca Says Cancer Drugs Enhertu, Tagrisso Show Survival Benefits in Late-Stage Trials

MT Newswires Live
·
Sep 14

AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial

Dow Jones
·
Sep 14